These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 18596701)
1. With a little help from my friends: modulation of phagocytosis through TLR activation. Tricker E; Cheng G Cell Res; 2008 Jul; 18(7):711-2. PubMed ID: 18596701 [No Abstract] [Full Text] [Related]
2. The effect of different Burkholderia pseudomallei isolates of varying levels of virulence on toll-like-receptor expression. Feterl M; Govan BL; Ketheesan N Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S82-8. PubMed ID: 19121695 [TBL] [Abstract][Full Text] [Related]
6. gp96 leads the way for toll-like receptors. Harding CV Immunity; 2007 Feb; 26(2):141-3. PubMed ID: 17307701 [TBL] [Abstract][Full Text] [Related]
7. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Lahiri A; Das P; Chakravortty D Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576 [TBL] [Abstract][Full Text] [Related]
8. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens. Marcato LG; Ferlini AP; Bonfim RC; Ramos-Jorge ML; Ropert C; Afonso LF; Vieira LQ; Sobrinho AP Oral Microbiol Immunol; 2008 Oct; 23(5):353-9. PubMed ID: 18793356 [TBL] [Abstract][Full Text] [Related]
9. TLR signalling and phagosome maturation: an alternative viewpoint. Russell DG; Yates RM Cell Microbiol; 2007 Apr; 9(4):849-50. PubMed ID: 17346307 [No Abstract] [Full Text] [Related]
10. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants. Tamaki Y; Takakubo Y; Goto K; Hirayama T; Sasaki K; Konttinen YT; Goodman SB; Takagi M J Rheumatol; 2009 Mar; 36(3):598-608. PubMed ID: 19208601 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors and their role in host resistance to Toxoplasma gondii. Yarovinsky F Immunol Lett; 2008 Aug; 119(1-2):17-21. PubMed ID: 18617274 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors, inflammation and tumor in the human female reproductive tract. Yu L; Wang L; Chen S Am J Reprod Immunol; 2009 Jul; 62(1):1-8. PubMed ID: 19527227 [TBL] [Abstract][Full Text] [Related]
14. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Roelofs MF; Abdollahi-Roodsaz S; Joosten LA; van den Berg WB; Radstake TR Arthritis Rheum; 2008 Feb; 58(2):338-48. PubMed ID: 18240239 [No Abstract] [Full Text] [Related]
15. A notch in the toll belt. Hertzog P Immunity; 2008 Nov; 29(5):663-5. PubMed ID: 19006687 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and innate immunity. Kumar H; Kawai T; Akira S Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699 [TBL] [Abstract][Full Text] [Related]
17. '3d' effects on global immunity. Carter RW; Tough DF Nat Immunol; 2006 Feb; 7(2):127-8. PubMed ID: 16424888 [No Abstract] [Full Text] [Related]
18. Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells. Matsui K; Wirotesangthong M; Nishikawa A Int Arch Allergy Immunol; 2009; 149(2):167-72. PubMed ID: 19127075 [TBL] [Abstract][Full Text] [Related]
19. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. O'Neill LA Immunity; 2008 Jul; 29(1):12-20. PubMed ID: 18631453 [TBL] [Abstract][Full Text] [Related]